SCIENTIFIC FOUNDATIONS

COLLABORATE WITH THE INSTITUTE

RECEIVE INFORMATION

 

Dr. Moncayo Scientific Thesis - Interview

 

Q: Could you explain your scientific method in just a few words?

A: The interaction of physical, chemical or biological contaminants in the human body modifies the absorption of light, inducing changes that alter the electronic distribution of hydrogen atoms in lipids, glycides and carbohydrates. In turn, this induces changes in the visible light spectrum and produces absorption of light in far ultra-violet wavelengths and close to the X-ray wavelength.

Accordingly, chronic-degenerative diseases appear when the collagen glucosamine 4,6 phosphate contained in the eye and the skin modifies its refraction index (RI), which is inversely proportional to the speed and wavelength of light. Therefore, when this light passes through the eye, before reaching the retina it produces changes in the refraction and speed of visible light, causing physiological alterations and diseases. In other words, knowing that the speed of light is 186,000 miles/sec, that the RI in air and vacuum equals 1 and assuming that the cornea and the skin have a RI of 1, there would be no changes in the speed of light or its wavelengths. However, if the cornea or skin modify their RI to 1.5, the light absorption would change.

 

Q: Could you give an example?

A: If the cornea changes its refraction ratio to 1.5 and the incoming light is of 600 nanometres, it will change to 400 nanometers and therefore the speed of light would go down to 124,220 miles/sec. In addition, the spin of electrons in the hydrogen atoms of scotopsins and rhodopsins in the retina will also change, causing the loss of nuclear and inter-molecular magnetic resonance of the body vis-à-vis-à-vis the electrical, magnetic and gravitational fields of the Earth. On this basis we assume that the changes induced in the refractory elements of the human body (the skin and the cornea) produce alterations in the electrons of hydrogen atoms in proteins, hormones, carbohydrates, leukotriens, inflammatory substances and others. This facilitates the expression of various and diverse diseases, including inflammatory and non-inflammatory joint diseases such as rheumatoid arthritis and osteoarthrosis.

 

Q: Could you summarize the therapy you practice?

A: Our research is mainly based on inhibiting or in other words readjusting IR anomalies originated by physical, chemical or biological contaminants so that, following principles of physics, the changes in light absorption can be reverted inducing a reverse image, under the principle that peaks and valleys cancel each other out. The result of this interaction is the readjustment or resetting of electrons at the inter-molecular level which brings about an inhibition of the inflammatory response or the physiopathological mechanism which is active in chronic-degenerative diseases.


 

 

 

MONCAYO RESEARCH INSTITUTE

ECATEPEC - MEXICO

MADRID - SPAIN

STOCKHOLM - SWEDEN

Coordination Phone: + 34609316277 (SPAIN)

 coordinacion.moncayo@gmail.com